Dias de Castro Eunice, Leblanc Ana, Barbosa Joselina, Ribeiro Laura, Cernadas Josefina R
Allergy and Clinical Immunology Department, Centro Hospitalar Universitário de S. João EPE, Porto, Portugal.
MedInUP- Center for Drug Discover and Innovative Medicines, Faculty of Medicine, University of Porto, Porto, Portugal.
Asia Pac Allergy. 2020 Oct 21;10(4):e39. doi: 10.5415/apallergy.2020.10.e39. eCollection 2020 Oct.
Several studies demonstrate an important association between allergic diseases and patients' psychological characteristics.
To evaluate any differences in the psychological characteristics of patients studied for suspected drug allergy in comparison with healthy controls. A secondary aim was to assess differences between patients with confirmed versus excluded drug allergy, with respect to the clinical aspects.
The psychological characteristics of 115 consecutive patients >16 years-old, studied for suspected drug allergy were assessed. They were compared with healthy controls. Four validated questionnaires were used to evaluate anxiety, depression, alexithymia, and personality type.
Eighty-eight patients completed the evaluation: 34 had confirmed drug allergy and 33 excluded. Forty-eight healthy subjects filled the 4 questionnaires. Increased neuroticism was associated with increased odds of belonging to the excluded drug allergy group (odds ratio [OR], 1.374; 95% confidence interval [CI], 1.173-1.609). Increased neuroticism (OR, 1.244; 95% CI, 1.065-1.453) and increased anxiety (OR, 1.210; 95% CI, 1.084-1.351) were associated with increased odds of confirmed drug allergy. However, higher extraversion decreased this likelihood (OR, 0.755; 95% CI, 0.643-0.888). The odds of having confirmed drug allergy was reduced by 79.7% (OR, 0.203; 95% CI, 0.060-0.694) for patients with 2 suspected drugs and by 84.6% (OR, 0.154; 95% CI, 0.029-0.809) for those with ≥3 in comparison to those with only one. Patients with moderate to severe reactions were more likely to have confirmed drug allergy (OR, 4.295; 95% CI, 1.105-16.693) than those with milder manifestations.
Our results highlight that patients with drug allergy have a distinctive psychological profile. Psychological assessment may help to identify patients that would benefit from a targeted intervention.
多项研究表明过敏性疾病与患者的心理特征之间存在重要关联。
评估疑似药物过敏患者与健康对照者在心理特征上的差异。次要目的是评估确诊与排除药物过敏的患者在临床方面的差异。
对115名年龄大于16岁的连续疑似药物过敏患者的心理特征进行评估。将他们与健康对照者进行比较。使用四份经过验证的问卷来评估焦虑、抑郁、述情障碍和人格类型。
88名患者完成了评估:34名确诊药物过敏,33名排除。48名健康受试者填写了这4份问卷。神经质增加与被排除在药物过敏组的几率增加相关(优势比[OR],1.374;95%置信区间[CI],1.173 - 1.609)。神经质增加(OR,1.244;95% CI,1.065 - 1.453)和焦虑增加(OR,1.210;95% CI,1.084 - 1.351)与确诊药物过敏的几率增加相关。然而,较高的外向性降低了这种可能性(OR,0.755;95% CI,0.643 - 0.888)。与仅有1种疑似药物的患者相比,有2种疑似药物的患者确诊药物过敏的几率降低了79.7%(OR,0.203;95% CI,0.060 - 0.694),有≥3种疑似药物的患者降低了84.6%(OR,0.154;95% CI,0.029 - 0.809)。有中度至重度反应的患者比表现较轻的患者更有可能确诊药物过敏(OR,4.295;95% CI,1.105 - 16.693)。
我们的结果突出表明药物过敏患者具有独特的心理特征。心理评估可能有助于识别那些将从针对性干预中受益的患者。